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Rs 2856717 Effect on the Clinical Manifestations and Poor Outcome of
IgA Nephropathy
Wei Wang, Guisen Li, Yurong Zou, Ping Zhang, Li Wang
Sichuan Provincial People’s Hospital, Chengdu, China
Objectives: To replicate the association of 7 single nucleotide polymorphisms
(SNPs; which were identified as strong association with IgAN in a genome-wide
association study) and investigate whether the 7 SNPs influence the clinical
manifestation and prognostic for IgAN patients, a case-control genetic study
from an independent western Han cohort was conducted.
Methods: Genomic DNA was extracted from 521 patients with IgAN and 535
healthy controls, and TaqMan allelic discrimination assay was used to type
SNP polymorphism. Traditional linear logistic regression analyses were
used to detect 7 SNP associations in dominant, recessive and additive ge-
netic models. Bonferroni correction was used to adjust the P-values for mul-
tiple testing. A total of 459 IgAN patients with integrated clinical data were
investigated the relationship between the genotype and phenotype of IgAN.
315 IgAN patients were followed-up. Then, a retrospective cohort study of
315 IgAN patients was conducted to explore the relationship between geno-
type and the progression of renal disease over a mean period of
44.49 19.94 months.
Results: After Bonferroni correction, no significant SNP association was
observed between IgAN patients and controls (Pc > 0.05). For genotype-
phenotype correlation studies, marginally significant association of rs
2856717 T/C recessive model for the T allele was significantly associated
with eGFR (< 60 ml/min) of IgAN patients (P Z 0.008, Pc Z 0.056,
OR Z 1.527). T allele at position of rs9275596 was significantly associated
with macroscopic hematuria of IgAN patients under the dominant and addi-
tive models of inheritance (P < 0.001, Pc Z 0.007, OR Z 2.983) and
(P < 0.001, PcZ 0.007, ORZ 2.17), respectively. Results from Kaplan-Meier
analysis showed that patients carrying the TT+TC genotype for rs2856717
had reduce renal survival rate than patients carrying the CC genotype
(85.1% vs. 92.7%, P Z 0.046).
Conclusion: Rs 2856717 may influence the clinical manifestations and poor
outcome of IgAN. Further studies are required to definition of the mecha-
nistic effects of genetic variants on clinical traits.Age at biopsy 36.92 (14.97) 36.35 0.821
Sex (male, % in same
category)
31 (34%) 16 (64%) 0.008
Baseline creatinine 152.74 (137.40) 183.53 (178.21) 0.163
http://dx.doi.org/10.1016/j.hkjn.2015.08.1150287
Effect of FK506 on IgA Nephropathy Rats with Mesangial Cell
Proliferation
Lin Ting Wei, Zhe Wang, Li Ning Jia, Jin Han, Xiao Tao Ma, Feng Ming Dong,
Rong Guo Fu
Department of Nephrology, Second Affiliated Hospital, Xi’an Jiaotong
University, Xi’an, Shaanxi Province, China
Objective: To investigate the effect of FK506 on IgAN rats with mesangial cell
proliferation and its relationship with TRPC ion channels and calcineurin.
Methods: IgAN model was established using “BSA + CCl4 + LPS” method, in
which rats were treated with 0.5, 1.0 mg/kg FK506 every day by intragastric
administration for 2 weeks. We measured the hematuria, proteinuria and the
renal function through the laboratory testing. HE staining were conducted to
observe the pathological conditions. RT-PCR and Western Blotting were per-
formed for detecting the rat renal cortical TRPC1, TRPC4/5, TRPC3/6/7 and
calcineurin mRNA and protein expressions.
Results: The levels of hematuria, proteinuria, serum BUN and sCr were elevated
in IgANgroupcomparedwithnormalgroup(P< 0.01),whichcouldbeameliorated
by treating with FK506 (P < 0.05), especially in high dose group (P < 0.01). HE
staining showed that the degree of kidney pathological damage was relatively
milder in high dose group in comparison with IgAN group. The mRNA and protein
levels of TRPC1 (P< 0.01), TRPC6 (P< 0.01, P< 0.05), calcineurin (P< 0.05) and
the protein expression of TRPC4/5 (P < 0.01) in IgAN group were also increased
compared with normal group. FK506 significantly down-regulated TRPC subtypes
and calcineurin mRNA and protein levels in IgAN rats (P < 0.05).
Conclusion: FK506 can significantly reduce the degree of hematuria and pro-
teinuria, improve renal function in IgAN rats, inhibit theproliferation ofmesan-
gial cell. The effect of FK506 on inhibiting mesangial cell proliferation may be
associated with the inhibition of the TRPC ion channels and calcineurin.
Funding: This work was supported by NSFC No. 81300581, 81470968,
81400740, 81100530.http://dx.doi.org/10.1016/j.hkjn.2015.08.116
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Outcome of IgAN With or Without Crescent FormationdA
Restrospective Kidney Survival Analysis
S. K. Chan, H. L. Lo, Y. W. Ho, C. H. Tam, W. C. A. Tang, C. K. D. Lam,
S. H. S. Wong
United Christian Hospital, Hong Kong
Background: Crescentic IgAN (IgA nephropathy) is known to cause rapid
renal function deterioration, similar to other form of IgAN. However
outcome of IgAN with crescent less than 50% glomeruli in Chinese population
is not well understood. Here we included more than 100 patients with
maximal follow up more than 20 years and examined their kidney survival
with or without crescent formation.
Methods:Current patients under the care of our unitwith diagnosis of IgANwere
examination. Patients without full biopsy report were excluded. Baseline char-
acteristics were compared between the two groups. Cox regression analysis was
usedtocompare thekidneysurvival,afteradjusting thebaselinecharacteristics.
End point was defined as either doubling of serum creatinine or starting of RRT,
whichevercameearlier. Survivalwas censored ifpatientdiedbeforeendpointor
kidney survived beyond the end of the study which was 30 June 2015.
Results:191patientswereexaminedand76wereexcluded.Theirbaselinechar-
acteristics are summarized in Table 1. After adjustment was performed, it was
found that presence of crescent itself did not have significant impact on kidney
survival (Table2). Ithas tobenotedthatwhentheonly1casewithmore than50%
crescent formation and poor kidney survival (time from diagnosis to dialysis less
than 2 months) was included to the group with crescent, the result still showed
no significant difference between the two test groups.(umol/L)
(continued )
No crescent With crescent P value
Baseline proterinuria
(gram/day)
2.22 (2.55) 2.89 (3.25) 0.233
Hypertension 35 (38,9%) 10 (40%) 0.920
Diabetes mellitus 2 (2.2%) 2 (8%) 0.165
Other glomerulonephritis
on biopsy
1 (1.1%) 2 (8%) 0.057
History of ischaemic heart
disease
1 (1.1%) 0 (0%) 0.598
Use of ACEI more than
1 year
67 (74.4%) 19 (76%) 0.875
Use of ARB more than
1 year
34 (37.8%) 10 (40%) 0.840
Immunosuppressant 0.003
Not used 58 (64.4%) 7 (28%)
Steroid alone 26 (28.9%) 13 (52%)
Steroid plus other
immunosuppressants
6 (6.7%) 5 (20%)
Table 2 Cox regression analysis with adjustment.
P value Odds
ratio
95% confidence
interval
Lower Upper
Sex <0.005 0.284 0.140 0.576
Age 0.235 0.984 0.957 1.011
Baseline creatinine <0.005 1.014 1.010 1.018
Baseline proteinuria <0.005 1.163 1.069 1.265
HT 0.609 1.170 0.642 2.130
DM <0.005 15.716 3.140 78.663
Other glomerulonephritis on
biopsy
0.382 0.347 0.032 3.718
Use of ACEI more than 1 year <0.005 5.288 1.653 16.881
Use of ARB more than 1 year 0.054 2.033 0.989 4.181
No crescent 0.296 0.647 0.285 1.464
Steroid alone 0.956 1.021 0.492 2.120
Steroid plus other
immunosuppressants
0.377 0.608 0.202 1.833
IgA Nephropathy S41Conclusion: Similar to other studies, our present work showed patients of
IgAN with less than 50% glomeruli having crescent formation, has similar kid-
ney survival compared to those without crescents, after adjusting for likely
predicting factors. However this retrospective review cannot conclude that
such similarity is due to natural disease process or use of ACEI/ARB or immu-
nosuppressants. Prospective study is required to answer this question.http://dx.doi.org/10.1016/j.hkjn.2015.08.117
0289
Effects of Interleukin-10 Polymorphisms (rs1800872, rs1800871 and
rs1800896) on IgA Nephropathy in Chinese Han Population
Jie Gao, Rong-Guo Fu, Lin-Ting Wei
Department of Nephrology, Second Affiliated Hospital, Medical School of
Xi’an Jiaotong University, Xi’an, China
Background: Previous investigations indicated that IL-10 polymorphisms play
important roles in many aspects of IgA nephropathy (IgAN) pathogenesis. The
aim of this study was to investigate the association of IL-10 polymorphisms
(rs1800872, rs1800871, and rs1800896) with IgAN in Chinese Han population.
Methods: In this study, we conducted a caseecontrol study involving 351
Chinese IgAN patients and 310 age, sex and ethnicity-matched healthy con-
trols. Three tag-SNPs (rs1800872, rs1800871 and rs1800896) of IL-10 were
genotyped by Sequenom MassARRAY. We used SPSS 18.0 for statistical anal-
ysis and SNP Stats to test for associations between tSNPs and the risk of IgAN
in five different models.
Results:We found that the allele frequencies were similar in patient and con-
trol groups, and both the A allele of rs1800872 and T allele of rs1800871 had
increased IgAN risk. The rs1800872 had significant association with increasedIgAN risk in four differentmodels (the codominantmodel, overdominantmodel,
the Log-additive mode and the dominant model). For rs1800871, the TC in the
codominant model, overdominant model, the Log-additive mode and TC/CC in
the dominant model were associated with increased IgAN risk. The rs1800896
had no relationship with IgAN risk. In haplotype analysis, we found that the
ATA and CCA haplotypewasmore frequent in patients with IgAN and the control
group (PZ 0.0312 and 0.0225, respectively). Moreover,we found that the urine
protein results suggested that the rs1800896 GA, GA/GG genotypes had
increased risk of IgAN compared with those individuals with AA genotype.
Conclusion: These findings indicated that the variants of rs1800871 and
rs1800872of IL-10genewere significantlyassociatedwith the IgAN risk inChinese
Han population. CCA haplotype was associated with increased IgAN risk. The
variant of the rs1800896 was related with the urine protein in IgAN patients.http://dx.doi.org/10.1016/j.hkjn.2015.08.118
0302
Clinical and Pathological Features of IgA Nephropathy Patients with
Hyperhomocysteinemia
Rui Ma, Yun-hua Liao, Yu-zhen Luo
Institution of Nephrology, Nanning, Guangxi, China
Objective: To study the clinical and pathological features of IgA nephropa-
thy patients with hyperhomocysteinemia.
Methods: A cross-sectional study was carried out. The IgA nephropathy pa-
tients were divided into hyperhomocysteinemia group and non-hyperhomo-
cysteinemia group, compared the clinical and pathological features
between the two groups.
Results: There were 82 IgA nephropathy patients enrolled in the study, 85.4%
of these Patients with hyperhomocysteinemia. The hyperhomocysteinemia
group with the higher serum urea nitrogen, higher serum creatinine, higher
serum uric acid and lower eGFR, also with the more serious glomerular scle-
rosis and renal tubular atrophy/fibrosis than the non-hyperhomocysteinemia
group (p < 0.05). Single factor correlation analysis showed that in IgA ne-
phropathy patients the serum homocysteine level were positively correlated
with the weight mass index, blood pressure, blood urea nitrogen, serum
creatinine, serum uric acid, glomerular sclerosis, renal tubular atrophy/C
fibrosis, and negatively correlated with the eGFR and hemoglobin
(p < 0.05). Multiple linear regression analysis showed that serum homocys-
teine level was a independent risk factor for eGFR decline.
Conclusion: It’s common that hyperhomocysteinemia in patients with IgA
nephropathy, IgA patients with hyperhomocysteinemia always showed the
more serious clinical and pathological damage, hyperhomocysteinemia was
a independent risk factors for kidney function decline.http://dx.doi.org/10.1016/j.hkjn.2015.08.119
0303
Urinary Albumin-to-Creatinine Ratio, Protein-to-Creatinine Ratio and
24-Hour Protein Excretion: Which is Best in Predicting Prognosis of IgA
Nephropathy?
Yanfeng Zhao1,2, Li Zhu1,2, Lijun Liu1,2, Sufang Shi1,2, Jicheng Lv1,2,
Hong Zhang1,2
1Renal Division, Department of Medicine, Peking University First Hospital,
Beijing, China
2Peking University Institute of Nephrology, Beijing, China
Objective: Proteinuria is proved to be independent predictor for IgA nephrop-
athy (IgAN) progression. Urine albumin-creatinine ratio (ACR), protein-creati-
nine ratio (PCR) and 24 hours urine protein excretion (UPE) are widely used
for evaluation of proteinuria in clinical practice. However, studies focused on
comparison of these measurements are limited. Here, we evaluated the asso-
ciation of ACR, PCR and 24h UPE with clinical and histological findings of
IgAN, and further explored the best measurement in predicting IgAN prognosis.
Methods: In total, 438 patients with IgAN were enrolled. Measurement of
spot urine ACR, spot urine PCR and 24h UPE at renal biopsy were performed
on automatic biochemical analyzer. Information of clinical and pathological
manifestations of enrolled patients was collected from medical records.
Results: In patients with IgAN, ACR, PCR and 24h UPE were highly correlated.
All of them showed ideal relationships with acknowledged markers reflecting
